HIV BLOG: NIAID's Dr. Carl Dieffenbach Discusses Key HIV Research Advances from CROI 2022

Tuesday, February 22, 2022 NIAID's Dr. Carl Dieffenbach Discusses Key HIV Research Advances from CROI 2022 In a video interview, NIAID's Dr. Carl Dieffenbach describes and contextualizes some of the pivotal HIV research advances presented last week at the 2022 Conference on Retroviruses and Opportunistic Infections (CROI 2022). Director of the NIAID Division of AIDS, Dr. Dieffenbach discusses key developments in HIV cure, treatment and prevention research and their implications. Watch the conversation and read summaries of the study findings on the NIAID Now blog. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107